Report cover image

PharmaZell GmbH - Strategic SWOT Analysis Review

Publisher GlobalData
Published Jun 29, 2022
Length 26 Pages
SKU # GBDT17311449

Description

PharmaZell GmbH - Strategic SWOT Analysis Review

- provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Highlights

PharmaZell GmbH (PharmaZell), a subsidiary of Bridgepoint Advisers Ltd develops and produces generic active pharmaceutical ingredients (API) and intermediates. The company also offers formulation development services. Its major products include generic APIs and amino acids. It provides a wide range of API-related services for diverse phases of the drug development process for producers of generic drugs and for originators in the pharmaceutical industry. The development services range from evaluation to registration includes project management, finished dosage form, process R&D, analytical R&D, pilot scale manufacturing API, pilot scale manufacturing FDF and regulatory documentation. The company has manufacturing facilities in Raubling, Germany; Gropello, Italy; and Chennai and Vizag, India. PharmaZell is headquartered in Raubling, Germany.

PharmaZell GmbH Key Recent Developments

Jan 27,2022: PharmaZell Group will be attending CPHI 2021 – make appointments to visit us in Milano at booth 18J10
Sep 16,2021: PharmaZell and Novasep enter into exclusive negotiations in new drive to create a technology-driven leader for complex small molecules and ADCs of global scale
Jul 27,2021: Pharma Zell(India) Private awarded EcoVadis Silver Medal in recognition for Sustainability Performance

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note:Some sections may be missing if data is unavailable for the company.

Table of Contents

26 Pages
Section 1 - About the Company
PharmaZell GmbH - Key Facts
PharmaZell GmbH - Key Employees
PharmaZell GmbH - Key Employee Biographies
PharmaZell GmbH - Major Products and Services
PharmaZell GmbH - History
PharmaZell GmbH - Company Statement
PharmaZell GmbH - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
PharmaZell GmbH - Business Description
PharmaZell GmbH - SWOT Analysis
SWOT Analysis - Overview
PharmaZell GmbH - Strengths
PharmaZell GmbH - Weaknesses
PharmaZell GmbH - Opportunities
PharmaZell GmbH - Threats
PharmaZell GmbH - Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
PharmaZell GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2016 to YTD 2022
PharmaZell GmbH, Pharmaceuticals & Healthcare, Deals By Type, 2016 to YTD 2022
PharmaZell GmbH, Recent Deals Summary
Section 4 – Company’s Recent Developments
Jan 27, 2022: PharmaZell Group will be attending CPHI 2021 – make appointments to visit us in Milano at booth 18J10
Sep 16, 2021: PharmaZell and Novasep enter into exclusive negotiations in new drive to create a technology-driven leader for complex small molecules and ADCs of global scale
Jul 27, 2021: Pharma Zell(India) Private awarded EcoVadis Silver Medal in recognition for Sustainability Performance
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
PharmaZell GmbH, Key Facts
PharmaZell GmbH, Key Employees
PharmaZell GmbH, Key Employee Biographies
PharmaZell GmbH, Major Products and Services
PharmaZell GmbH, History
PharmaZell GmbH, Subsidiaries
PharmaZell GmbH, Key Competitors
PharmaZell GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2016 to YTD 2022
PharmaZell GmbH, Pharmaceuticals & Healthcare, Deals By Type, 2016 to YTD 2022
PharmaZell GmbH, Recent Deals Summary
List of Figures
PharmaZell GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2016 to YTD 2022
PharmaZell GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2016 to YTD 2022

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us